［1］Bhan A,Soleimani M, Mandal SS. Long noncoding RNA and cancer: A new paradigm\[J\]. Cancer Res, 2017, 77(15):3965-3981.［2］李琪儿, 叶国良, 郭俊明. lncRNA:肿瘤分子诊断中的一颗新星\[J\]. 中国生物化学与分子生物学报, 2014, 30(3):233-240.［3］张学军, 汤虎成, 刘飞. 长链非编码RNA Gas5在非小细胞肺癌中的表达及意义\[J\]. 临床肺科杂志, 2015,20(2):239-242.［4］White NM，Cabanski CR，SilvaFisher JM，et al. Transeriptome sequencing reveals altered long intergenic noncoding RNAs in lung cancer\[J\]. Genome Biol, 2014, 15(8):429.［5］Wapinski O, Chang HY. Long noncoding RNAs and human disease\[J\]. Trends Cell Biol, 2011, 21(6):354-361.［6］Booton R, Lindsay MA. Emerging role of microRNA and long noncoding RNAs in respiratory disease\[J\]. Chest, 2014, 146(1):193-204.［7］Yang F, Bi J,Xue X, et al. Upregulated long noncoding RNA H19 contributes to proliferation of gastric cancer cells\[J\]. FEBS J, 2012, 279(17):3159-3165.［8］Zhang H, Chen Z, Wang X, et al. Long noncoding RNA: a new player in cancer\[J\]. J Hematol Oncol, 2013, 6:37. doi:10.1186/17568722637.［9］Bhan A, Mandal SS. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer \[J\]. Biochim Biophys Acta, 2015, 1856(1):151-164.［10］Huang X, Yuan T, Tschannen M, et al. Characterization of human plasmaderived exosomal RNAs by deep sequencing \[J\]. BMC Genomics, 2013, 14:319. doi: 10.1186/1471216414319.［11］Zhang K, Luo Z, Zhang Y, et al. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer\[J\]. Cancer Biomark, 2016, 17(2):187-194.［12］杨哲锋, 李娟, 马志元,等. 血浆LncRNAHEIH表达水平与肝癌发病风险的关联分析\[J\]. 现代肿瘤医学, 2015,23(1):80-84.［13］Pickard MR, Williams GT. Regulation of apoptosis by long noncoding RNA GAS5 in breast cancer cells: implications for chemotherapy\[J\]. Breast Cancer Res Treat, 2014, 145(2):359-370.［14］Sun M, Jin FY, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer\[J\]. BMC Cancer, 2014, 14:319.［15］YacqubUsman K, Pickard MR, Williams GT. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells\[J\]. Prostate, 2015, 75(7):693-705.［16］Zhang N, Yang GQ, Shao XM, et al. GAS5 modulated autophagy is a mechanism modulating cisplatin sensitivity in NSCLC cells\[J\]. Eur Rev Med Pharmacol Sci, 2016, 20(11):2271-2277.［17］Liang W, Lv T, Shi X, et al. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer\[J\]. Medicine (Baltimore), 2016, 95(37):e4608.［18］Shi X, Sun M, Liu H, et al. A critical role for the long noncoding RNA GAS5 in proliferation and apoptosis in nonsmallcell lung cancer\[J\]. Mol Carcinog, 2015, 54(S1):E1-E12.［19］黄琦, 沙辉, 陈龙, 等. 多发性骨髓瘤和慢性淋巴细胞白血病患者血浆lncRNA MALAT1、LincRNAp21和GAS5的表达水平及其诊断意义\[J\]. 吉林大学学报(医学版),2018,44(2): 339-345.［20］Nissan A, Stojadinovic A, MitraniRosenbaum S, et al. Colon cancer associated transcript1: A novel RNA expressed in malignant and premalignant human tissues\[J\]. Int J Cancer,2012, 130(7):1598-1606.［21］Li Y, Zhu G, Ma Y, et al. LncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR2191\[J\]. J Cell Biochem, 2017, doi:10.1002/jcb.26560.［22］Liang D, Yang SB, Xu FF,et al. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let7 sponge\[J\]. J Exp Clin Cancer Res, 2015, 34(1):1-10.［23］Lu L, Qi H, Luo F, et al. Feedback circuitry via let7c between lncRNA CCAT1 and cMyc is involved in cigarette smoke extractinduced malignant transformation of HBE cells\[J\]. Oncotarget, 2017, 8(12):19285-19297.
2019, Vol. 29 
